This report identifies the influenza vaccine market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to influenza vaccine market.
Globally North America dominated the market for influenza vaccine in 2015 with highest market share due to higher awareness about impacts of influenza and its outbreaks amongst its citizen coupled with developed medical and healthcare establishment in the region. North America was followed by Asia-Pacific and Europe as the second and third largest regional market respectively, for influenza vaccine. However, Asia-Pacific is expected to be fastest growing regional segment during the period of study due to fast growing healthcare setup in the region especially in India and China along with growing awareness about the influenza in the region.
This report on global influenza vaccine covers different type of influenza vaccine based vaccine type and also classifies the global influenza market based on the target group, and end-use industries and market size in various geographical regions.
On the basis of delivery method of the influenza vaccine, this report is segmented into two major segments as follows: Nasal Spray and Injection
This reports is also classified on the basis of age group and medical condition of the target audience, based on this global influenza market is classified into four major segments as follows: Infants, Children, Adults (Pregnant Women and Others) and Elderly People
This is report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for influenza vaccine in each of the region.
This report identifies all the major companies operating in the global influenza vaccine market. Some of the major companies’ profiles in detail are as follows:
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis
4. Influenza Vaccine – Market Forces
4.1.1. Growing cases of global outbreak of influenza epidemics
4.1.2. Increasing awareness in the developing nations
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Influenza Vaccine – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Influenza Vaccine Market, By Vaccine Type
6.2. Nasal Spray
7. Influenza Vaccine Market, By Target Group
7.3.1. Pregnant Women
7.4. Elderly People
8. Influenza Vaccine Market, By Geography
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.4. Rest of the World (RoW)
8.4.2. Rest of RoW
9. Influenza Vaccine – Market Entropy
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract
10. Company Profiles (By- Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
10.2. Novartis Inc.
10.4. Abott Laboratories
10.5. Pfizer Inc.
10.7. Hualan Bio
10.8. Changchun Bio
10.9. Fluarix & Flulaval
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11.3. Research Methodology
11.4. Expert Insights